CINCINNATI--(BUSINESS WIRE)--Sept. 21, 2006--Meridian Bioscience,
Inc. (NASDAQ:VIVO) today announced that the Company has been invited
to present at the UBS Global Life Sciences Conference, Tuesday,
September 26, 2006 at 1:30 p.m. ET at the Grand Hyatt New York in New
York City. Bill Motto, Chairman and CEO and Jack Kraeutler, President
and COO, are scheduled to present. A question and answer session will
follow and some of the information provided during the session may not
have been previously disclosed. Mr. Motto and Mr. Kraeutler will be
available to meet with investors during the Conference.
Meridian invites investors to listen to management's remarks, live
over the Internet at 1:30 p.m. ET on September 26, on the Company's
website at www.meridianbioscience.com. The archived broadcast will be
available at 4:30 p.m. on September 26, 2006 until October 28, 2006.
Meridian is a fully integrated life science company that
manufactures, markets and distributes a broad range of innovative
diagnostic test kits, purified reagents and related products and
offers biopharmaceutical enabling technologies. Utilizing a variety of
methods, these products provide accuracy, simplicity and speed in the
early diagnosis and treatment of common medical conditions, such as
gastrointestinal, viral, urinary and respiratory infections. All
Meridian diagnostic products are used outside of the human body and
require little or no special equipment. The Company's products are
designed to enhance patient well-being while reducing the total
outcome costs of healthcare. Meridian has strong market positions in
the areas of gastrointestinal and upper respiratory infections,
serology, parasitology and fungal disease diagnosis. In addition,
Meridian is a supplier of rare reagents and specialty biologicals
along with proteins and other biologicals used by biopharmaceutical
companies engaged in research for new drugs and vaccines. The Company
markets its products to hospitals, reference laboratories, research
centers, veterinary testing centers, physician offices and diagnostics
manufacturers in more than 60 countries around the world. The
Company's shares are traded through Nasdaq's National Market, symbol
VIVO. Meridian's website address is www.meridianbioscience.com.
CONTACT: Meridian Bioscience, Inc.
John A. Kraeutler, 513-271-3700
SOURCE: Meridian Bioscience, Inc.